GBE50 Attenuates Inflammatory Response by Inhibiting the p38 MAPK and NF-<i>κ</i>B Pathways in LPS-Stimulated Microglial Cells

<table>The effect of GBE50 on the morphology of BV2 cells between treated and untreated groups. (a) The morphology of BV2 cells in the control group. (b) The morphology of BV2 cells activated by LPS. (c)–(g) The effect of GBE50 at indicated concentrations on the morphology of BV2 cells activated by LPS. (h) The effect of EGB761 (10 <i>μ</i>g/mL) on the morphology of BV2 cells activated by LPS. All images were low magnification (10x objective lens) photomicrographs of unstained BV2 cells. Scale bar = 50 <i>μ</i>m.</table>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: GBE50 Attenuates Inflammatory Response by Inhibiting the p38 MAPK and NF-<i>κ</i>B Pathways in LPS-Stimulated Microglial Cells 

Evidence-Based Complementary and Alternative Medicine

GBE50 Attenuates Inflammatory Response by Inhibiting the p38 MAPK and NF-κB Pathways in LPS-Stimulated Microglial Cells

Figure 2